KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Non-Current Deferred Tax Liability: 2013-2025

Historic Non-Current Deferred Tax Liability for Emergent BioSolutions (EBS) over the last 7 years, with Sep 2025 value amounting to $36.3 million.

  • Emergent BioSolutions' Non-Current Deferred Tax Liability fell 13.37% to $36.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.3 million, marking a year-over-year decrease of 13.37%. This contributed to the annual value of $41.7 million for FY2024, which is 29.20% down from last year.
  • Emergent BioSolutions' Non-Current Deferred Tax Liability amounted to $36.3 million in Q3 2025, which was down 21.94% from $46.5 million recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Non-Current Deferred Tax Liability registered a high of $130.7 million during Q4 2021, and its lowest value of $34.8 million during Q1 2024.
  • For the 3-year period, Emergent BioSolutions' Non-Current Deferred Tax Liability averaged around $47.8 million, with its median value being $46.5 million (2025).
  • Per our database at Business Quant, Emergent BioSolutions' Non-Current Deferred Tax Liability spiked by 114.91% in 2022 and then slumped by 53.99% in 2023.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Non-Current Deferred Tax Liability stood at $130.7 million in 2021, then dropped by 4.06% to $125.4 million in 2022, then crashed by 53.03% to $58.9 million in 2023, then declined by 29.20% to $41.7 million in 2024, then decreased by 13.37% to $36.3 million in 2025.
  • Its last three reported values are $36.3 million in Q3 2025, $46.5 million for Q2 2025, and $60.4 million during Q1 2025.